Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for CV protection in chronic dialysis patients (ARCADIA)
NCT00985322Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- May 2009
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramipril in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Mario Negri Institute for Pharmacological Research. Started May 2009; status: completed.
02
Drugs
ramipril
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00985322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985322.